Nilandron Oral Tablet 150Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Nilandron: Oral tablet (150mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Nilandron 150mg Tab

What is this Medicine?

NILUTAMIDE (nye LOO ta mide) blocks the effect of the male hormone called testosterone. It is used with surgery to treat prostate cancer.

CVS Pharmacy Patient Statistics for Nilandron: Oral tablet(150mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Nilandron 150mg Tablet

NDC: 000881111
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Prostate Cancer

Storage Information
Protect from light
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Nilandron 150mg Tablet

Reported Side Effects for Nilandron 150mg Tablet

Flushing Incidence:
<5.0%*
Severity: MILD
Onset: RAPID
Pulmonary Fibrosis Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Aplastic Anemia Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Low Blood Pressure Incidence:
<5.0%*
Severity: MODERATE
Onset: RAPID
Visual Impairment Incidence:
<56.9%*
Severity: SEVERE
Onset: EARLY
Itching Incidence:
2.0%*
Severity: MILD
Onset: RAPID
Lung Inflammation Incidence:
2.0%*
Severity: MODERATE
Onset: DELAYED
Light Sensitivity Incidence:
2.0%*
Severity: MODERATE
Onset: EARLY
Dry Mouth Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Cataracts Incidence:
2.0%*
Severity: MODERATE
Onset: DELAYED
Intestinal Bleeding Incidence:
2.0%*
Severity: SEVERE
Onset: DELAYED
Melena Incidence:
2.0%*
Severity: MODERATE
Onset: DELAYED
Rhinitis Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Swelling Incidence:
2.0%*
Severity: MODERATE
Onset: DELAYED
Loose Stools Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Cough Incidence:
2.0%*
Severity: MILD
Onset: DELAYED
Feeling Sick Incidence:
2.0-5.0%*
Severity: MILD
Onset: EARLY
Fainting Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Nervousness Incidence:
2.0%*
Severity: MILD
Onset: DELAYED
Weight Loss Incidence:
2.0%*
Severity: MILD
Onset: DELAYED
Chest Pain Incidence:
2.0%*
Severity: MODERATE
Onset: EARLY
Low White Blood Cell Counts Incidence:
3.0%*
Severity: MODERATE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
3.0-12.9%*
Severity: MODERATE
Onset: DELAYED
Paresthesias Incidence:
3.0%*
Severity: MILD
Onset: DELAYED
Heart Failure Incidence:
3.0%*
Severity: SEVERE
Onset: DELAYED
Increased Blood Sugar Incidence:
4.0%*
Severity: MODERATE
Onset: DELAYED
High Blood Pressure Incidence:
5.3-9.1%*
Severity: MODERATE
Onset: EARLY
Hypoesthesia Incidence:
5.3%*
Severity: MILD
Onset: DELAYED
Skin Rash Incidence:
5.3%*
Severity: MILD
Onset: EARLY
Fever Incidence:
5.3%*
Severity: MILD
Onset: EARLY
Infection Incidence:
5.3-8.6%*
Severity: MILD
Onset: DELAYED
Hair Loss Incidence:
5.7%*
Severity: MILD
Onset: DELAYED
Vomiting Incidence:
5.7%*
Severity: MILD
Onset: EARLY
Shortness Of Breath Incidence:
6.2-10.5%*
Severity: MODERATE
Onset: EARLY
Bone Pain Incidence:
6.2%*
Severity: MODERATE
Onset: DELAYED
Excessive Sweating Incidence:
6.2%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
6.7%*
Severity: MILD
Onset: EARLY
Nighttime Urination Incidence:
6.7%*
Severity: MILD
Onset: EARLY
Constipation Incidence:
7.1-19.6%*
Severity: MODERATE
Onset: DELAYED
Lightheadedness Incidence:
7.1-10.0%*
Severity: MILD
Onset: EARLY
Flu Incidence:
7.2%*
Severity: MILD
Onset: DELAYED
Anemia Incidence:
7.2%*
Severity: MODERATE
Onset: DELAYED
Chest Pain Incidence:
7.2%*
Severity: MODERATE
Onset: EARLY
Blood In The Urine Incidence:
8.1%*
Severity: MODERATE
Onset: DELAYED
Depression Incidence:
8.6%*
Severity: MODERATE
Onset: DELAYED
Upset Stomach Incidence:
9.8-23.9%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
10.0%*
Severity: MILD
Onset: EARLY
Gynecomastia Incidence:
10.5%*
Severity: MILD
Onset: DELAYED
Impotence (erectile Dysfunction) Incidence:
11.0%*
Severity: MODERATE
Onset: DELAYED
Decreased Sexual Desire Incidence:
11.0%*
Severity: MILD
Onset: DELAYED
Decreased Appetite Incidence:
11.0%*
Severity: MILD
Onset: DELAYED
Back Pain Incidence:
11.5%*
Severity: MILD
Onset: DELAYED
Fluid Retention Incidence:
12.4%*
Severity: MODERATE
Onset: DELAYED
Headache Incidence:
13.9%*
Severity: MILD
Onset: EARLY
Inability To Sleep Incidence:
16.3%*
Severity: MILD
Onset: EARLY
Testicular Atrophy Incidence:
16.3%*
Severity: MODERATE
Onset: DELAYED
Weakness Incidence:
19.1%*
Severity: MILD
Onset: DELAYED
Hot Flashes Incidence:
28.4-66.5%*
Severity: MODERATE
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Nilandron 150mg Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Moderate Lifestyle Interaction
Alcohol and Nilandron 150mg Tablet(Nilutamide)
Alcohol and Nilutamide(Nilutamide)
You may wish to limit the intake of Alcoholic beverages while taking Nilutamide. Taking Alcohol with Nilutamide can cause reactions like facial flushing, dizziness (especially on standing), or generally feeling unwell. You may also feel drowsy or more tired when taking these drugs together. Do not drive or operate machinery if you have been drinking alcohol.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Nilandron

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5